Bioequivalence of Nilotinib 200 mg Capsules in Healthy Participants Under Fasting Conditions.
This study is for healthy volunteers and is designed to compare different versions of a medicine called nilotinib. The aim is to see if a new nilotinib 200mg capsule is absorbed and used by the body in the same way as an established version, especially when taken without food. This type of research is called a 'bioequivalence' study. It helps ensure that new medicines, or new forms of existing ones, deliver the right amount of active ingredient into your bloodstream, just like the original. This is important for patient safety and to make sure the medicine will work as expected when prescribed for conditions it's approved to treat, even though this study is with healthy people.
At a glance
What is this study about?
Imagine a specific medicine that helps treat a particular illness. Sometimes, different companies might make their own versions of this medicine, or a company might change how it's made. To make sure all these versions work just as well and are safe, studies like this one are done.
This study is focusing on a medicine called nilotinib. Its main purpose is to check if a new 200mg nilotinib capsule acts the same inside the body as a version that is already well-known. This is especially important when the medicine is taken on an empty stomach, as food can sometimes change how medicines are absorbed.
The fancy name for this kind of check is a 'bioequivalence study.' It means scientists are comparing how much of the medicine gets into your bloodstream and how quickly it gets there. If they find that the new version is 'bioequivalent,' it means it works just like the original in your body. This research is a crucial step to make sure future patients who need nilotinib get a medicine that is consistent and effective.
Key takeaways
- This study compares different nilotinib capsules to ensure they work the same.
- It's for healthy adults aged 18 and over.
- Participation involves taking medicine on an empty stomach and giving blood samples.
- It helps ensure future patients receive a reliable medicine.
- You can stop participating at any time.
Who may be eligible?
This study is looking for healthy adults. This means you should not have any ongoing medical conditions or take regular medicines that might interfere with the study.
To be considered, you need to be at least 18 years old. There isn't an upper age limit mentioned, so older adults who are generally healthy might also be able to take part. Both men and women are welcome to join this study.
Since this study involves taking medication, the research team will do careful health checks to make sure it's safe for you to participate. They will likely ask about your health history and perform some tests.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally healthy and don't have any ongoing medical conditions?
- Are you able to visit the study clinic for multiple appointments?
- Are you comfortable taking a study medicine on an empty stomach?
- Are you willing to have blood samples taken regularly during visits?
What does participation involve?
If you decide to take part, you would be asked to visit the study site for several appointments. During these visits, you would receive the nilotinib capsule to take on an empty stomach. You would likely stay at the clinic for a period of time after taking the medicine so the study team can collect blood samples at specific intervals. This helps them measure how the medicine moves through your body.
There might be an initial screening visit to check if you're suitable, followed by a few visits where you receive the medication and have samples taken. You would also have follow-up appointments to make sure you're feeling well and to check for any lasting effects. The total time for your involvement would depend on the study's specific schedule, but bioequivalence studies typically involve a few stays at the clinic over several weeks.
Potential risks and benefits
Locations (1)
- —UnverifiedPortugal
Common questions
What is nilotinib normally used for?
Nilotinib is typically used to treat certain types of cancer, but this study involves healthy people to understand how the medicine behaves in the body.
Why do you need healthy people for this study?
Using healthy people helps researchers clearly see how the medicine works in the body without other health conditions or medicines affecting the results.
Will I have to stay overnight at the clinic?
Yes, it's common for bioequivalence studies to require overnight stays at the clinic so researchers can take blood samples at specific times after you take the medicine.
Will I get paid for taking part?
Many studies like this offer payment for your time and travel expenses. The study team will provide details on any compensation.
What does taking medicine 'under fasting conditions' mean?
It means you will take the medicine when you haven't eaten anything for a certain period, usually overnight, before taking the dose.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.